Ivey Business School (Canada)
-
GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues — Open Labs, Open Minds (B)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M110-EStrategyThis case is a supplement to GSK’s Andrew Witty (A).Starting at €5.74
-
GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues — The Pharmaceutical Patent Pool (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M109-EStrategyIn February 2009, Andrew Witty, CEO of GlaxoSmithKline (GSK), reflected on his vision for big pharma as a catalyst for change which focussed on two key issues: 1) promoting innovation for the products that treat or prevent neglected tropical diseases and 2) improving access to medicines in the world’s poorest countries. He had announced the creation of the Pharmaceutical Patent Pool and wondered if it was the right strategy to deliver results on ...Starting at €8.20
-
Time Out: A New Global Strategy to Bring Back Profit
Christopher Williams; Umair ShafiqueCase IVEY-9B17M063-EEntrepreneurship, StrategyIn June 2016, the chief executive officer (CEO) of the United Kingdom-based Time Out Group PLC (Time Out), had just taken the company through an initial public offering, raising much-needed capital for investment and growth. Time Out, which provided consumers with information, tickets, and access to theatre, concerts, and events, as well as food, drink, and cultural experiences in its Time Out Market, had reported significant losses in 2014 and 2...Starting at €8.20